Lithium carbonate
- Generic Name
- Lithium carbonate
- Brand Names
- Carbolith, Lithane, Lithmax, Lithobid
- Drug Type
- Small Molecule
- Chemical Formula
- CLi2O3
- CAS Number
- 554-13-2
- Unique Ingredient Identifier
- 2BMD2GNA4V
Overview
Lithium has been used to treat manic episodes since the 19th century. Though it is widely used, its mechanism of action is still unknown. Lithium carbonate has a narrow therapeutic range and so careful monitoring is required to avoid adverse effects.
Background
Lithium has been used to treat manic episodes since the 19th century. Though it is widely used, its mechanism of action is still unknown. Lithium carbonate has a narrow therapeutic range and so careful monitoring is required to avoid adverse effects.
Indication
Lithium carbonate is indicated as a monotherapy for the treatment of acute manic and mixed episodes associated with bipolar 1 disorder in patients ≥7 years of age. It is also indicated as a maintenance treatment for bipolar 1 disorder in patients ≥7 years of age.
Associated Conditions
- Bipolar 1 Disorder
- Mixed manic depressive episode
- Acute Manic episode
Clinical Trials
FDA Approved Products
Singapore Approved Products
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.